ARCHIVES

HHS Reinvention May Include Privatizing Of NIH Clinical Center

This article is from The Cancer Letter archive.

Vol. 21 No. 20 | May 19, 1995

Download PDF Visit The Full Archive

Related Articles

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

Minority Trial Participation A Matter of Access, Study Says

December 30, 2005

Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief.

December 19, 2008

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

Changes In Clinical Trials Mechanism Inevitable, But NCI Says It will Heed Critics Of Proposals

April 18, 1986